Circular RNA circ_0020014 contributes to osteoarthritis progression via miR-613/ADAMTS5 axis.
Journal
Bosnian journal of basic medical sciences
ISSN: 1840-4812
Titre abrégé: Bosn J Basic Med Sci
Pays: Bosnia and Herzegovina
ID NLM: 101200947
Informations de publication
Date de publication:
16 Sep 2022
16 Sep 2022
Historique:
received:
27
10
2021
accepted:
23
01
2022
pubmed:
1
3
2022
medline:
28
9
2022
entrez:
28
2
2022
Statut:
epublish
Résumé
Circular RNAs (circRNAs) have been shown to be significant regulators in osteoarthritis (OA), whereas the functional effect of circ_0020014 in OA remains unclear. Our goal was to try and understand the underlying regulatory mechanism of circ_0020014 in OA. The cartilage tissue was obtained from OA patients and trauma patients. Interleukin-1β (IL-1β)-treated chondrocytes (CHON-001) were used as the in vitro cellular model for OA. The expression levels of circ_0020014, microRNA-613 (miR-613), and a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5) were examined by real-time quantitative polymerase chain reaction (RT-qPCR). The protein level was detected using the western blot assay. Cell viability and apoptosis were measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazol-3-ium bromide (MTT) and flow cytometry assays, respectively. The secretion of inflammatory cytokine was determined by enzyme-linked immunosorbent assay (ELISA). Circ_0020014 was upregulated in OA cartilage tissues and IL-1β-treated CHON-001 cells, compared with that in healthy cartilage tissues and untreated cells. IL-1β treatment induced cell injury by promoting inflammation and apoptosis, and inhibiting cell viability and extracellular matrix (ECM) accumulation in chondrocytes. Circ_0020014 knockdown significantly protected CHON-001 cells from IL-1β-induced cell dysfunction. MiR-613 was targeted by circ_0020014 and negatively regulated ADAMTS5 expression. In addition, miR-613 downregulation or ADAMTS5 overexpression partly lessened the protective effect of circ_0020014 knockdown on IL-1β-treated CHON-001 cells. Collectively, circ_0020014 acted as a miR-613 sponge to regulate ADAMTS5 expression, thereby protecting chondrocytes from IL-1β-induced inflammatory damage, which might be a novel diagnostic marker for OA.
Identifiants
pubmed: 35225755
doi: 10.17305/bjbms.2021.6668
pmc: PMC9519163
doi:
Substances chimiques
Bromides
0
Disintegrins
0
Interleukin-1beta
0
MIRN613 microRNA, human
0
MicroRNAs
0
RNA, Circular
0
Thrombospondins
0
ADAMTS5 Protein
EC 3.4.24.-
ADAMTS5 protein, human
EC 3.4.24.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
716-727Références
Biomed Res Int. 2013;2013:284873
pubmed: 24069595
Cancer Manag Res. 2020 Dec 08;12:12623-12633
pubmed: 33324107
Mol Med Rep. 2018 Jul;18(1):541-549
pubmed: 29749508
Ageing Res Rev. 2017 Nov;40:20-30
pubmed: 28774716
Cell Signal. 2018 Apr;44:33-42
pubmed: 29339084
Yonsei Med J. 2019 Nov;60(11):1081-1092
pubmed: 31637891
Onco Targets Ther. 2018 Apr 30;11:2429-2438
pubmed: 29765228
Biosci Rep. 2020 Nov 27;40(11):
pubmed: 33094798
J Cell Biochem. 2011 Dec;112(12):3507-14
pubmed: 21815191
Cell Mol Biol Lett. 2019 Apr 19;24:8
pubmed: 31019537
Biorheology. 2002;39(1-2):237-46
pubmed: 12082286
Am J Transl Res. 2017 Mar 15;9(3):1213-1221
pubmed: 28386347
RNA Biol. 2015;12(4):381-8
pubmed: 25746834
Acta Orthop Traumatol Turc. 2019 Mar;53(2):140-144
pubmed: 30655094
Gene. 2018 Jun 15;659:168-174
pubmed: 29551505
Biol Rev Camb Philos Soc. 2018 Nov;93(4):1955-1986
pubmed: 29797774
Matrix Biol. 2018 Oct;71-72:225-239
pubmed: 29885460
Int J Mol Med. 2019 Feb;43(2):779-790
pubmed: 30569118
Biosci Rep. 2018 Oct 31;38(5):
pubmed: 30279209
Iowa Orthop J. 2001;21:1-7
pubmed: 11813939
Biomed Pharmacother. 2019 Oct;118:109309
pubmed: 31545237
Genet Test Mol Biomarkers. 2019 Oct;23(10):717-721
pubmed: 31526191
J Mol Med (Berl). 2016 Jun;94(6):681-94
pubmed: 26816250
Cell Mol Life Sci. 2019 Feb;76(3):441-451
pubmed: 30374521
Drug Des Devel Ther. 2019 Jul 23;13:2503-2512
pubmed: 31440033
Ann Rheum Dis. 2019 Jan;78(1):111-121
pubmed: 30287418
Clin Chim Acta. 2020 Feb;501:92-101
pubmed: 31678276
Theranostics. 2017 Jan 1;7(1):180-195
pubmed: 28042326
Ann Rheum Dis. 2019 Feb;78(2):270-277
pubmed: 30504444
J Cell Mol Med. 2018 Nov;22(11):5753-5758
pubmed: 30133133
Am J Transl Res. 2020 Sep 15;12(9):5308-5319
pubmed: 33042421
J Cell Physiol. 2019 May;234(5):5451-5465
pubmed: 30471116
Mol Med Rep. 2019 Oct;20(4):3308-3316
pubmed: 31432161
Biochem J. 2016 Jan 1;473(1):e1-4
pubmed: 26657033
Arthritis Rheum. 2013 Dec;65(12):3107-19
pubmed: 23982761
J Orthop Surg Res. 2019 May 3;14(1):118
pubmed: 31053150
Osteoarthritis Cartilage. 2017 Oct;25(10):1698-1707
pubmed: 28647469
Int Immunopharmacol. 2019 Jun;71:233-240
pubmed: 30925324
Nat Commun. 2019 Apr 23;10(1):1914
pubmed: 31015473
Schmerz. 2019 Feb;33(1):4-12
pubmed: 30560495
Nat Rev Dis Primers. 2016 Oct 13;2:16072
pubmed: 27734845